Dr. Jack Erter, MD
Dr. Jack Erter, MD
Physician, Tennessee Oncology
Master of Management in Health Care, Vanderbilt University
Dr. Jack W. Erter III has 13 years of experience in the fields of Internal Medicine, Hematology, and Medical Oncology. He earned his BS in Chemistry from Davidson College, his MD from the Medical University of South Carolina College of Medicine, and his MMH from Vanderbilt University. After completing both an internship and residency in Internal Medicine at Vanderbilt University Medical Center, he went on to complete a fellowship in Hematology and Oncology at Ohio State University Hospital. Today, this expert is board certified in Internal Medicine, Hematology, and Medical Oncology. Formerly, he served as a Physician in Private Practice. Currently, he serves as a Physician with Tennessee Oncology.
j********@t*****.com
(615) ***-****
Nashville, Tennessee
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
Media & News
110
Social Media Mentions
2808
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|---|---|
Anna Bognar, et al. v. Monsanto Co. | Other | 2018-05-30 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Title | Type |
|---|---|
Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 110 records
Title | Description |
|---|---|
Considering Outpatient Use of Tagraxofusp for BPDCN in ... | Aug 31, 2023 -- Jonathan Abbas, MD (MODERATOR). Medical Director, Ascension Saint Thomas ... Jack Erter, MD | Chirag Amin, DO | Daniel Vaena, MD. Event Region ... |
Number Of Oncologists in Nashville | SmartScrapers | Aug 11, 2023 -- Jack W. Erter, M.D., Jack W. Erter, M.D., 397 Wallace Rd # 201, Nashville, TN 37211, United States, Nashville, Tennessee, United States ... |
Abbas Looks at the Use of Ruxolitinib and Fedratinib in ... | May 30, 2023 -- A 68-year-old woman presented to her physician with symptoms of mild fatigue, moderate night sweats and ... JACK ERTER, MD: I'll echo that. |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
Vanderbilt University | Master of Management in Health Care |
Medical University of South Carolina College of Medicine | Doctor of Medicine |
Davidson College | Bachelor of Science |
Work History
Title | Employer |
|---|---|
Physician | Tennessee Oncology |
Physician | Self-Employed |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3-5 days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
